Insider Trading History of Sedor John A

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Sedor John A since 2007. The trader's CIK number is 1337409. At the time of the last reporting, Sedor John A was the President of Cpex Pharmaceuticals, Inc.. (stock ticker symbol CPEX). Also see all insider trading activities at Cpex Pharmaceuticals, Inc..

Note that in the past Sedor John A also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Bentley Pharmaceuticals Inc (BNT) by Sedor John A

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2008 BNT 0 $0 0 $0 5,800 $0
2007 BNT 0 $0 0 $0 2,300 $0

Yearly summary of insider trading at Cpex Pharmaceuticals, Inc. (CPEX) by Sedor John A

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 CPEX 0 $0 0 $0 146,875 $0
2009 CPEX 600 $5,273 0 $0 0 $0
2008 CPEX 3,600 $64,248 0 $0 0 $0


Insider trading activities at 2 companies by Sedor John A:

1. Bentley Pharmaceuticals Inc (BNT)

2. Cpex Pharmaceuticals, Inc. (CPEX)

Table 1. Insider trading of Bentley Pharmaceuticals Inc (BNT) by Sedor John A

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2008-05-23 BNT Option Ex 5,800 .00 0
2007-05-23 BNT Option Ex 2,300 .00 0

Table 2. Insider trading of Cpex Pharmaceuticals, Inc. (CPEX) by Sedor John A

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-04-05 CPEX Option Ex 146,875 .00 0
2009-08-17 CPEX Buy 600 8.79 5,273
2008-08-20 CPEX Buy 3,000 17.83 53,484
2008-08-19 CPEX Buy 600 17.94 10,764

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sedor John A (President of Cpex Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.